I was suprised to see reports that Congress doesn’t see a way to stop 5,000 percent hikes in price for a medicine.
A new law isn’t needed. Anti-trust laws have been used to force companies to give up purchased assets that were being used to allow monopolistic pricing.
This would seem to be a classic example. The argument against squeezing the profits of a company that makes investments, and risks loss to develop new medicines, do not apply at all to a case like this.
Tom Heyns
Chelsea
Send questions/comments to the editors.
Related Stories
Latest Articles
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have a commenting profile? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.